Acceleration of leukocytes’ epigenetic age as an early tumor and sex-specific marker of breast and colorectal cancer
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
// Danielle Fernandes Durso 1, 2, * , Maria Giulia Bacalini 3, * , Claudia Sala 4, 9 , Chiara Pirazzini 3 , Elena Marasco 1 , Massimiliano Bonafé 1 , Ítalo Faria do Valle 4 , Davide Gentilini 5 , Gastone Castellani 4, 9 , Ana Maria Caetano Faria 6 , Claudio Franceschi 3, * , Paolo Garagnani 1, 7, 8, 9, * , Christine Nardini 10, 11, * 1 Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum-University of Bologna, Bologna, Italy 2 National Counsel of Technological and Scientific Development (CNPq), Ministry of Science Technology and Innovation (MCTI), Brasilia, Brazil 3 IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy 4 Department of Physics and Astronomy, University of Bologna, Bologna, Italy 5 Istituto Auxologico Italiano IRCCS, Cusano Milanino, Milan, Italy 6 Biochemistry and Immunology Department, Biological Sciences Institute, Federal University of Minas Gerais, Belo Horizonte, Brazil 7 Applied Biomedical Research Center, S. Orsola-Malpighi Polyclinic, Bologna, Italy 8 Interdepartmental Center “L. Galvani”, University of Bologna, Bologna, Italy 9 Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden 10 Personal Genomics S.r.l., Verona, Italy 11 CNR IAC “Mauro Picone”, Rome, Italy * These authors contributed equally to this work Correspondence to: Christine Nardini, email: christine.nardini.rsrc@gmail.com Paolo Garagnani, email: paolo.garagnani2@unibo.it Claudio Franceschi, email: claudio.franceschi@unibo.it Keywords: epigenetic clock, ELOVL2, FHL2, cancer, blood Received: October 19, 2016 Accepted: February 12, 2017 Published: February 21, 2017 ABSTRACT Changes in blood epigenetic age have been associated with several pathological conditions and have recently been described to anticipate cancer development. In this work, we analyze a publicly available leukocytes methylation dataset to evaluate the relation between DNA methylation age and the prospective development of specific types of cancer. We calculated DNA methylation age acceleration using five state-of-the-art estimators (three multi-site: Horvath, Hannum, Weidner; and two CpG specific: ELOV2 and FHL2) in a cohort including 845 subjects from the EPIC-Italy project and we compared 424 samples that remained cancer-free over the approximately ten years of follow-up with 235 and 166 subjects who developed breast and colorectal cancer, respectively. We show that the epigenetic age estimated from blood DNA methylation data is statistically significantly associated to future breast and male colorectal cancer development. These results are corroborated by survival analysis that shows significant association between age acceleration and cancer incidence suggesting that the chance of developing age-related diseases may be predicted by circulating epigenetic markers, with a dependence upon tumor type, sex and age estimator. These are encouraging results towards the non-invasive and perspective usage of epigenetic biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA methylation age of human tissues and cell types
Horvath, S. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r115 · Cited by 7,075
Genome-wide methylation profiles reveal quantitative views of human aging rates
Hannum, G., Guinney, J., Zhao, L., Zhang, L., Hughes, G., Sadda, S., Klotzle, B., Bibikova, M., Fan, J.-B., Gao, Y., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.016 · Cited by 4,270 · cited 1×
“[29] and relies on the DNA methylation values of 71 CpG sites (only six being in common with Horvath’s) from the Infinium HumanMethylation450 BeadChip (HM450).”
MethodAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
Riboli, E., Hunt, K., Slimani, N., Ferrari, P., Norat, T., Fahey, M., Charrondière, U., Hémon, B., Casagrande, C., Vignat, J., et al. (2002) · Public Health Nutrition · doi:10.1079/phn2002394 · Cited by 1,866 · cited 1×
“The Italian EPIC cohort consists of 47,749 people recruited in the centers of Ragusa (6,404 subjects), Florence (13,597 subjects), Turin (10,604 subjects), Naples (5,062 subjects, women only) and Milan (12,079 subjects) [46, 47].”
BackgroundDNA methylation age of blood predicts all-cause mortality in later life
Marioni, R. E., Shah, S., McRae, A. F., Chen, B. H., Colicino, E., Harris, S. E., Gibson, J., Henders, A. K., Redmond, P., Cox, S. R., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0584-6 · Cited by 1,261 · cited 1×
“Three studies demonstrated the association of this epigenetic clock with biological fitness and mortality [25, 26, 28], as well as its association with post-traumatic stress disorders [32].”
BackgroundDNA methylation-based measures of biological age: meta-analysis predicting time to death
Chen, B. H., Marioni, R. E., Colicino, E., Peters, M. J., Ward-Caviness, C. K., Tsai, P.-C., Roetker, N. S., Just, A. C., Demerath, E. W., Guan, W., et al. (2016) · Aging · doi:10.18632/aging.101020 · Cited by 1,126
Epigenetic regulation of ageing: linking environmental inputs to genomic stability
Benayoun, B. A., Pollina, E. A., & Brunet, A. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4048 · Cited by 610 · cited 1×
“higher biological than chronological age) could be predictive, if not causative, of the development of several diseases, including cancer [11].”
BackgroundPerna, L., Zhang, Y., Mons, U., Holleczek, B., Saum, K.-U., & Brenner, H. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0228-z · Cited by 572
HIV-1 infection accelerates age according to the epigenetic clock
Horvath, S., & Levine, A. J. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv277 · Cited by 556
Methylation of ELOVL 2 gene as a new epigenetic marker of age
Garagnani, P., Bacalini, M. G., Pirazzini, C., Gori, D., Giuliani, C., Mari, D., Di Blasio, A. M., Gentilini, D., Vitale, G., Collino, S., et al. (2012) · Aging Cell · doi:10.1111/acel.12005 · Cited by 473
Self-citation
Cited by
DNA methylation-based biomarkers and the epigenetic clock theory of ageing
Horvath, S., & Raj, K. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0004-3 · Cited by 3,095
The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates
Franceschi, C., Garagnani, P., Morsiani, C., Conte, M., Santoro, A., Grignolio, A., Monti, D., Capri, M., & Salvioli, S. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00061 · Cited by 945
“In many different studies, Horvath’s clock has proven to grasp features of accelerated aging in many different age-related clinical conditions such as cancer (237, 238), neurodegeneration (239–241), progeroid genetic syndromes other than DS, such as Werner syndrome (242), and all-cause mortality (243, 244).”
BackgroundSelf-citationDNA Methylation Clocks in Aging: Categories, Causes, and Consequences
Field, A. E., Robertson, N. A., Wang, T., Havas, A., Ideker, T., & Adams, P. D. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.08.008 · Cited by 621
Fransquet, P. D., Wrigglesworth, J., Woods, R. L., Ernst, M. E., & Ryan, J. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0656-7 · Cited by 369
Measuring Aging and Identifying Aging Phenotypes in Cancer Survivors
Guida, J. L., Ahles, T. A., Belsky, D., Campisi, J., Cohen, H. J., DeGregori, J., Fuldner, R., Ferrucci, L., Gallicchio, L., Gavrilov, L., et al. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz136 · Cited by 216
Metadata
- Authors
- Durso, D. F., Bacalini, M. G., Sala, C., Pirazzini, C., Marasco, E., Bonafé, M., do Valle, Í. F., Gentilini, D., Castellani, G., Faria, A. M. C., Franceschi, C., Garagnani, P., & Nardini, C.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-02-21
- Volume
- 8
- Issue
- 14
- Pages
- 23237-23245
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2590469096
- Cited by
- 107
- References
- 18
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acceleration of leukocytes’ epigenetic age as an early tumor and sex-specific marker of breast and colorectal cancer. https://app.cochat.ai/papers/10.18632/oncotarget.15573
- The paper
- Durso, D. F., Bacalini, M. G., Sala, C., Pirazzini, C., Marasco, E., Bonafé, M., do Valle, Í. F., Gentilini, D., Castellani, G., Faria, A. M. C., Franceschi, C., Garagnani, P., & Nardini, C. (2017). Acceleration of leukocytes’ epigenetic age as an early tumor and sex-specific marker of breast and colorectal cancer. Oncotarget. https://doi.org/10.18632/oncotarget.15573
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.